Benzinga's Top Upgrades

Analysts at Citigroup upgraded Fossil FOSL from “neutral” to “buy.” Fossil's shares closed at $85.09 yesterday. Fossil's trailing-twelve-month ROE is 28.93%. Analysts at Wells Fargo upgraded Lorillard LO from “market perform” to “outperform.” Lorillard's shares closed at $115.45 yesterday. Lorillard's trailing-twelve-month revenue is $4.50 billion. Analysts at Jefferies upgraded The Medicines Company MDCO from “hold” to “buy.” Medicines Company's stock closed at $23.98 yesterday. Medicines Company's trailing-twelve-month operating margin is 12.58%. Analysts at RW Baird upgraded Sprint Nextel S from “underperform” to “neutral.” Sprint's shares closed at $5.69 yesterday. Sprint's trailing-twelve-month revenue is $34.63 billion.